Follow
Aljohani B, Badr Aljohani, BADER A MARWANI, BA Aljohani
Aljohani B, Badr Aljohani, BADER A MARWANI, BA Aljohani
1Researcher, King Abdullah International Medical Research Centre, King Saud Bin Abdulaziz University
Verified email at qmul.ac.uk - Homepage
Title
Cited by
Cited by
Year
Adverse drug reactions spontaneously reported at a tertiary care hospital and preventable measures implemented
LC Abu Esba, G Al Mardawi, MI AlJasser, B Aljohani, A Abu Alburak
Journal of Clinical Pharmacy and Therapeutics 46 (2), 460-469, 2021
152021
Forensic toxicology: drug use and misuse
D Holt
Royal Society of Chemistry, 2016
132016
Development and validation of a HPLC-UV method for dissolution testing of ciclosporin: its application to the measurement of brand and generic versions from different countries
B Aljohani, FF Alotaibi, E Ghazaly, JA Jaber, D Perrett, A Johnston
J. Bioequiv. Availab 9, 509-519, 2017
92017
Prospects of Establishing a Saudi Version of the United States Food and Drug Administration Orange Book
RA Yazed AlRuthia, Badr Aljohani, Wejdan R. Alsharif, Hala H. Alrasheed ...
Health Policy and Technology, 2020
4*2020
Therapeutics discovery: From bench to first in-human trials
EM Al-Hujaily, T Khatlani, Z Alehaideb, R Ali, B Almuzaini, BM Alrfaei, ...
Biomedical Reports 8 (3), 275-282, 2018
22018
Pharmaceutical Bioequivalence Studies: Ensuring Safety, Effectiveness and High Quality
BA Aljohani
Queen Mary University of London, 2016
2016
Substandard and Counterfeit Medicines
B Aljohani
2016
Development and validation of a hplc method for ciclosporin: its application to measurement of brand and generic versions from different countries
B Aljohani, F Al Otaibi, E Ghazaly, D Perrett, A Johnston
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 73 (6), 1007-1007, 2012
2012
The system can't perform the operation now. Try again later.
Articles 1–8